EquitySectoral/ ThematicDirect · Growth
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
HDFC · Scheme 152082
₹21.93▼ 0.27%NAV · 2026-08-05
Excellent FundScore
AUM
—
Expense ratio
—
3Y CAGR
—
Risk (SEBI)
—
Min SIP
—
Benchmark
—
NAV Growth
Loading NAV history…
Historical returns
| Period | Return |
|---|---|
| 1 Month | +2.45% |
| 3 Months | +13.99% |
| 6 Months | +27.07% |
| 1 Year | +23.61% |
| 3 Years (CAGR) | — |
| 5 Years (CAGR) | — |
| 10 Years (CAGR) | — |
| Since Launch | +32.10% |
Returns ≥ 1 year are annualised (CAGR); shorter periods are absolute. Past performance does not guarantee future returns.
FundScore breakdown
Six explainable dimensions. How the score works →
Returns100
Consistency50
Risk-adjusted95
Downside protection97
Cost efficiency80
Portfolio quality50
Why this fund scores well
- ✓ 1Y return: +23.6%
- ✓ 1Y return vs category: +15.2% vs category avg
- ✓ Sharpe ratio: 1.63
- ✓ Sortino ratio: 2.19
- ✓ Max drawdown: -15%
Risk metrics
Sharpe ratio
1.63
Sortino ratio
2.19
Volatility
14.17%
Max drawdown
-14.91%
Downside capture
47.00%
SIP return calculator
Back-tested on this fund's actual historical NAVs. Past performance ≠ future returns.
Portfolio & holdings
Top holdings, sector allocation and market-cap split require a paid factsheet feed and are coming soon. Everything above is computed from official daily NAV history and is fully real.